UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

PIK3CA, BRAF, and PTEN Status and Benefit from Cetuximab in the Treatment of Advanced Colorectal Cancer―Results from NCIC CTG/AGITG CO.17

Clinical cancer research, 2014-02, Vol.20 (3), p.744-753

2014

Volltextzugriff (PDF)

A lack of association between BMI and chemoimmunotherapy efficacy in advanced non-small cell lung cancer: Secondary analysis of the IMpower150 and IMpower130 clinical trials

BMC cancer, 2024-03, Vol.24 (1), p.379-8, Article 379

2024

Volltextzugriff (PDF)

Does the Chemotherapy Backbone Impact on the Efficacy of Targeted Agents in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis of the Literature

PloS one, 2015-08, Vol.10 (8), p.e0135599

2015

Volltextzugriff (PDF)

Phase I dose-escalation study to determine the safety, tolerability, preliminary efficacy and pharmacokinetics of an intratumoral injection of tigilanol tiglate (EBC-46)

EBioMedicine, 2019-12, Vol.50, p.433-441

2019

Volltextzugriff (PDF)

Conventional myelosuppressive chemotherapy for non-haematological malignancy disrupts the intestinal microbiome

BMC cancer, 2021-05, Vol.21 (1), p.1-591, Article 591

2021

Volltextzugriff (PDF)

The association of health-care contact days with physical function and survival in CCTG/AGITG CO.17

JNCI : Journal of the National Cancer Institute, 2024-08, Vol.116 (8), p.1313-1318

2024

Volltextzugriff (PDF)

A longitudinal cohort study of watch and wait in complete clinical responders after chemo-radiotherapy for localised rectal cancer: study protocol

BMC cancer, 2022-03, Vol.22 (1), p.222-222, Article 222

2022

Volltextzugriff (PDF)

Online information and support needs of women with advanced breast cancer: a qualitative analysis

Supportive care in cancer, 2018-10, Vol.26 (10), p.3489-3496

2018

Volltextzugriff (PDF)

Proton Pump Inhibitors and Survival in Patients With Colorectal Cancer Receiving Fluoropyrimidine-Based Chemotherapy

Journal of the National Comprehensive Cancer Network, 2021-09, Vol.19 (9), p.1037-1044

2021

Volltextzugriff (PDF)

The Use of Circulating Tumor DNA for Prognosis of Gastrointestinal Cancers

Frontiers in oncology, 2018-07, Vol.8, p.275-275

2018

Volltextzugriff (PDF)

The Australian Medical Oncologist Workforce Survey: The profile and challenges of medical oncology

Seminars in oncology, 2018-10, Vol.45 (5-6), p.284-290

2018

Volltextzugriff (PDF)

Localised prostate cancer in elderly men aged 80–89 years, findings from a population‐based registry

BJU international, 2018-05, Vol.121 (S3), p.48-54

2018

Volltextzugriff (PDF)

Mutant p53 Mediates Sensitivity to Cancer Treatment Agents in Oesophageal Adenocarcinoma Associated with MicroRNA and SLC7A11 Expression

International journal of molecular sciences, 2021-05, Vol.22 (11), p.5547

2021

Volltextzugriff (PDF)

Transverse Colon Primary Tumor Location as a Biomarker in Metastatic Colorectal Cancer: A Pooled Analysis of CCTG/AGITG CO.17 and CO.20 Randomized Clinical Trials

Clinical cancer research, 2024-03, Vol.30 (6), p.1121-1130

2024

Volltextzugriff (PDF)

Survival outcomes for patients with colorectal cancer with synchronous liver only metastasis

ANZ journal of surgery, 2023-07, Vol.93 (7-8), p.1847-1853

2023

Volltextzugriff (PDF)

First‐line therapy for metastatic colorectal cancer: Current perspectives and future directions

Asia-Pacific journal of clinical oncology, 2019-02, Vol.15 (S1), p.3-14

2019

Volltextzugriff (PDF)

RAS Mutations as Predictive Biomarkers in Clinical Management of Metastatic Colorectal Cancer

Clinical colorectal cancer, 2016-06, Vol.15 (2), p.95-103

2016

Volltextzugriff (PDF)

Expanded Low Allele Frequency RAS and BRAF V600E Testing in Metastatic Colorectal Cancer as Predictive Biomarkers for Cetuximab in the Randomized CO.17 Trial

Clinical cancer research, 2021-01, Vol.27 (1), p.52-59

2021

Volltextzugriff (PDF)

Risk Factors for Severe Diarrhea with an Afatinib Treatment of Non-Small Cell Lung Cancer: A Pooled Analysis of Clinical Trials

Cancers, 2018-10, Vol.10 (10), p.384

2018

Volltextzugriff (PDF)

Medical Oncology Group of Australia position statement and membership survey on voluntary assisted dying

Internal medicine journal, 2018-07, Vol.48 (7), p.774-779

2018

Volltextzugriff (PDF)

Response to the Letter to the Editor: Lung Immune Prognostic Index for Outcome Prediction to Immunotherapy in Patients With NSCLC

Journal of thoracic oncology, 2019-09, Vol.14 (9), p.e208-e208

2019

Volltextzugriff (PDF)

Gastrointestinal Adenocarcinoma Incidence and Survival Trends in South Australia, 1990-2017

Cancers, 2022-01, Vol.14 (2), p.275

2022

Volltextzugriff (PDF)

Evaluating the Time Toxicity of Cancer Treatment in the CCTG CO.17 Trial

JCO oncology practice, 2023-06, Vol.19 (6), p.e859-e866

2023

Volltextzugriff (PDF)

Meta-analysis comparing the efficacy of anti-EGFR monoclonal antibody therapy between KRAS G13D and other KRAS mutant metastatic colorectal cancer tumours

European journal of cancer (1990), 2016-03, Vol.55, p.122-130

2016

Volltextzugriff (PDF)

26 – 50 von 295

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(286)
Mit Volltextzugriff
(259)

Publikationsform

Artikel
(294)
Dissertationen
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(170)
Life Sciences & Biomedicine
(168)
Humans
(132)
Oncology
(127)
Female
(66)
Male
(63)
Chemotherapy
(62)
Middle Aged
(60)
Aged
(54)
Colorectal Cancer
(50)
Cancer
(48)
Survival
(39)
Adult
(37)
Colorectal Neoplasms - Pathology
(37)
Colorectal Neoplasms - Drug Therapy
(35)
Patients
(35)
Aged, 80 And Over
(34)
Mutation
(32)
Metastasis
(31)
Tumors
(31)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

PIK3CA, BRAF, and PTEN Status and Benefit from Cetuximab in the Treatment of Advanced Colorectal Cancer―Results from NCIC CTG/AGITG CO.17

A lack of association between BMI and chemoimmunotherapy efficacy in advanced non-small cell lung cancer: Secondary analysis of the IMpower150 and IMpower130 clinical trials

Does the Chemotherapy Backbone Impact on the Efficacy of Targeted Agents in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis of the Literature

Phase I dose-escalation study to determine the safety, tolerability, preliminary efficacy and pharmacokinetics of an intratumoral injection of tigilanol tiglate (EBC-46)

Conventional myelosuppressive chemotherapy for non-haematological malignancy disrupts the intestinal microbiome

The association of health-care contact days with physical function and survival in CCTG/AGITG CO.17

A longitudinal cohort study of watch and wait in complete clinical responders after chemo-radiotherapy for localised rectal cancer: study protocol

Online information and support needs of women with advanced breast cancer: a qualitative analysis

Proton Pump Inhibitors and Survival in Patients With Colorectal Cancer Receiving Fluoropyrimidine-Based Chemotherapy

The Use of Circulating Tumor DNA for Prognosis of Gastrointestinal Cancers

The Australian Medical Oncologist Workforce Survey: The profile and challenges of medical oncology

Localised prostate cancer in elderly men aged 80–89 years, findings from a population‐based registry

Mutant p53 Mediates Sensitivity to Cancer Treatment Agents in Oesophageal Adenocarcinoma Associated with MicroRNA and SLC7A11 Expression

Transverse Colon Primary Tumor Location as a Biomarker in Metastatic Colorectal Cancer: A Pooled Analysis of CCTG/AGITG CO.17 and CO.20 Randomized Clinical Trials

Survival outcomes for patients with colorectal cancer with synchronous liver only metastasis

First‐line therapy for metastatic colorectal cancer: Current perspectives and future directions

A comparison of DNA sequencing and gene expression profiling to assist tissue of origin diagnosis in cancer of unknown primary

RAS Mutations as Predictive Biomarkers in Clinical Management of Metastatic Colorectal Cancer

Expanded Low Allele Frequency RAS and BRAF V600E Testing in Metastatic Colorectal Cancer as Predictive Biomarkers for Cetuximab in the Randomized CO.17 Trial

Risk Factors for Severe Diarrhea with an Afatinib Treatment of Non-Small Cell Lung Cancer: A Pooled Analysis of Clinical Trials

Medical Oncology Group of Australia position statement and membership survey on voluntary assisted dying

Response to the Letter to the Editor: Lung Immune Prognostic Index for Outcome Prediction to Immunotherapy in Patients With NSCLC

Gastrointestinal Adenocarcinoma Incidence and Survival Trends in South Australia, 1990-2017

Evaluating the Time Toxicity of Cancer Treatment in the CCTG CO.17 Trial

Meta-analysis comparing the efficacy of anti-EGFR monoclonal antibody therapy between KRAS G13D and other KRAS mutant metastatic colorectal cancer tumours

Suchergebnisse filtern